Loading...

Karo Pharma AB (publ)

KARBF•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$5.25
$0.00(0.00%)

Karo Pharma AB (publ) (KARBF) Stock Overview

Explore Karo Pharma AB (publ)’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

F

Score: N/A

Key Financials

Market Cap1.5B
P/E RatioN/A
EPS (TTM)$0.02
ROEN/A
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$4.18

KARBF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Karo Pharma AB (publ) (KARBF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $4.18.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of N/A and a market capitalization of 1.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;